Status:
NOT_YET_RECRUITING
Fecal DNA Methylation Detection for Gastric Cancer
Lead Sponsor:
Fudan University
Conditions:
Gastric Adenocarcinoma
Eligibility:
All Genders
40+ years
Brief Summary
The study is a prospective, multicentre, cross-sectional study to evaluate the efficacy of fecal methylation-based testing in comparison with the 'gold standard' imaging tests, such as CT, gastroscopy...
Detailed Description
Aims of the study Primary study aim: To assess the sensitivity and specificity of fecal methylation site-based tests for the prediction of gastric cancer. Secondary research objectives: 1. the accura...
Eligibility Criteria
Inclusion
- Age ≥40 years, male or female.
- Have or will have gastroscopy and/or pathology results.
- No contraindications to endoscopy and able to cooperate with endoscopy.
- Patients must be able to fully understand the informed consent form and be able to sign the informed consent form in person.
Exclusion
- Have severe cardiac, hepatic, or renal insufficiency, or mental disorders.
- Previous history of upper gastrointestinal malignancy.
- Women during pregnancy.
- Those with unspecified pathology.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
10800 Patients enrolled
Trial Details
Trial ID
NCT06943807
Start Date
December 1 2025
End Date
December 30 2026
Last Update
June 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.